After a Massachusetts drug company paused its phase 1 study of a leukemia drug candidate in June following a study participant’s death, the FDA put a clinical hold on the trial Aug. 11.
HHS halted all research that involved human subjects at a New York City psychiatric hospital as the agency investigates a drug trial participant’s suicide, The New York Times reported Aug. 10.
A new American Heart Association scientific statement found that adequate levels of shared decision-making occur in only about 10 percent of face-to-face consultations.
In July, the CDC published findings indicating up to 450,000 people in the U.S. may have alpha-gal syndrome, a tick-borne meat allergy most clinicians are unfamiliar with.
A California physician had her license revoked after failing to complete the requirements of her probation, which were imposed after a patient’s death, The Bakersfield Californian reported Aug. 10.